BlockBeats News, September 22nd, Hong Kong-listed company JOINN Laboratories announced in a statement that the company and its subsidiary, ETHK Inc, and ETHK HOLDINGS LIMITED, have signed a $1.5 billion strategic cooperation agreement with Creative Medical Group Limited and its subsidiary Transcenta Oncology Inc. regarding the potential tokenization of innovative drug pipeline assets, RWA.
